| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/PR5009948 |
| P698 | PubMed publication ID | 25567202 |
| P50 | author | Facundo M Fernandez | Q81094735 |
| Maria Eugenia Monge | Q83937196 | ||
| P2093 | author name string | Martin M Matzuk | |
| Christina M Jones | |||
| Jaeyeon Kim | |||
| P2860 | cites work | HMDB: the Human Metabolome Database | Q23039065 |
| KEGG: kyoto encyclopedia of genes and genomes | Q24515297 | ||
| A novel protease homolog differentially expressed in breast and ovarian cancer | Q24654651 | ||
| Brick by brick: metabolism and tumor cell growth | Q24656187 | ||
| LMSD: LIPID MAPS structure database | Q24675592 | ||
| MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data | Q27136473 | ||
| MassBank: a public repository for sharing mass spectral data for life sciences | Q27809667 | ||
| Integrated genomic analyses of ovarian carcinoma | Q27860518 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| Bilirubin is an antioxidant of possible physiological importance | Q28288206 | ||
| Chemoprevention of mammary carcinogenesis by hydroxylated derivatives of d-limonene | Q28289414 | ||
| Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer | Q28478197 | ||
| MetaboSearch: tool for mass-based metabolite identification using multiple databases | Q28480894 | ||
| METLIN: a metabolite mass spectral database | Q29614808 | ||
| Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. | Q30452681 | ||
| Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines. | Q33495701 | ||
| The biology of ovarian cancer: new opportunities for translation | Q33622369 | ||
| Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells | Q33699139 | ||
| The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory | Q33739695 | ||
| Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells. | Q33897852 | ||
| Case-control study of phyto-oestrogens and breast cancer | Q34065312 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma | Q57942914 | ||
| Bilirubin attenuates radical-mediated damage to serum albumin | Q61663181 | ||
| Changes in plasma lipids, lipoproteins, triglyceride secretion and removal in chicks with estrogen implants | Q68455687 | ||
| Uroterpenol, a Pettenkofer chromogen of dietary origin and a common constituent of human urine | Q71227378 | ||
| Dietary fat intake and risk of epithelial ovarian cancer | Q72153985 | ||
| Studies on the Mechanism of Increased Plasma Triglyceride Levels Induced by Oral Contraceptives | Q72335264 | ||
| Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells | Q73169562 | ||
| Serum bilirubin and 10-year mortality risk in a Belgian population | Q77540450 | ||
| Ovarian cancer | Q82238526 | ||
| Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry | Q83395703 | ||
| Serum 27-nor-5β-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer | Q83763225 | ||
| Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers | Q85214889 | ||
| Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform | Q34142972 | ||
| Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer | Q34166286 | ||
| Anticarcinogens from fried ground beef: heat-altered derivatives of linoleic acid | Q34166625 | ||
| Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement | Q34298836 | ||
| Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism. | Q34321160 | ||
| Bile acids as carcinogens in human gastrointestinal cancers | Q34384551 | ||
| Natural products in anticancer therapy. | Q34441101 | ||
| Sex steroid influence on triglyceride metabolism | Q34482833 | ||
| Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. | Q34519901 | ||
| Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probe | Q34783824 | ||
| Metabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR Spectroscopy | Q34960082 | ||
| Natural products for cancer prevention: a global perspective | Q35153727 | ||
| Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. | Q35758403 | ||
| High-grade serous ovarian cancer arises from fallopian tube in a mouse model | Q35844827 | ||
| Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells | Q35982257 | ||
| p53 gene mutations and protein accumulation in human ovarian cancer | Q36328863 | ||
| Diagnosis and management of epithelial ovarian cancer | Q36493937 | ||
| Sphingosine kinase-1--a potential therapeutic target in cancer. | Q36679105 | ||
| Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers | Q36855240 | ||
| Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. | Q37400537 | ||
| Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor | Q40089549 | ||
| Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence | Q40189207 | ||
| A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu ( | Q40331476 | ||
| Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen. | Q40344896 | ||
| The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. | Q41120735 | ||
| The metabolic basis of cancer cachexia | Q41581051 | ||
| Dietary phytoestrogens and cancer: in vitro and in vivo studies | Q41638504 | ||
| De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation | Q42874677 | ||
| "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer | Q44049813 | ||
| Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling | Q44701486 | ||
| Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics | Q45119909 | ||
| Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass. | Q45941347 | ||
| Feasibility of detecting prostate cancer by ultraperformance liquid chromatography-mass spectrometry serum metabolomics. | Q45956913 | ||
| Rapid mass spectrometric metabolic profiling of blood sera detects ovarian cancer with high accuracy. | Q45962753 | ||
| PIK3CA is implicated as an oncogene in ovarian cancer. | Q46015944 | ||
| Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. | Q46245921 | ||
| Urinary hydrophilic and hydrophobic metabolic profiling based on liquid chromatography-mass spectrometry methods: Differential metabolite discovery specific to ovarian cancer. | Q49057114 | ||
| The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. | Q51141864 | ||
| Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors. | Q51565387 | ||
| Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. | Q52929104 | ||
| Aberrations in normal systemic lipid metabolism in ovarian cancer patients. | Q53458950 | ||
| The chick as a laboratory model for the study of estrogen-induced hyperlipidemia. | Q54426369 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 917-927 | |
| P577 | publication date | 2015-01-16 | |
| P1433 | published in | Journal of Proteome Research | Q3186939 |
| P1476 | title | Metabolomic serum profiling detects early-stage high-grade serous ovarian cancer in a mouse model | |
| P478 | volume | 14 |
| Q91763871 | Deep Metabolomics of a High-Grade Serous Ovarian Cancer Triple-Knockout Mouse Model |
| Q37643626 | Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors |
| Q37690743 | Metabolomic Biomarkers in Urine of Cushing's Syndrome Patients |
| Q90778331 | Metandem: An online software tool for mass spectrometry-based isobaric labeling metabolomics |
| Q57180544 | Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism |
| Q93148158 | Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts |
| Q91964975 | Proteome profiling of low grade serous ovarian cancer |
| Q50138072 | Serum metabolite profiling of cutaneous T-cell lymphoma based on a multiplatform approach. |
| Q41607194 | Short overview on metabolomics approach to study pathophysiology of oxidative stress in cancer |
| Q47888284 | Tumor Microenvironment and Models of Ovarian Cancer: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium |
| Q36012373 | Whole Reproductive System Non-Negative Matrix Factorization Mass Spectrometry Imaging of an Early-Stage Ovarian Cancer Mouse Model |
Search more.